Lecta to Increase CWF and UWF Prices by 6 to 7 percent

Q1/2018 highlights (vs Q1/2017 proforma): • Net sales EUR 572.4 million (EUR 566.9 million), an increase of 1.0%. In constant currency growth was 5.9%, driven by higher selling prices. • Continued good demand across most markets • Comparable EBITDA EUR 66.7 million (EUR 79.4 million), representing 11.7% (14.0%) of net sales in an environment of significant raw material cost escalation • Net profit EUR 21.2 million (EUR 24.2 million).

Matt Spence, Vice-President Biomaterials at Sappi Biotech explains: “Valida is a highly fibrillated cellulose manufactured by Sappi. Derived from woodfibre, it is a 100% natural, biodegradable and sustainable material. Valida can successfully perform as an opacifier and thickener in sanitising gels, providing a natural alternative for acrylate-based polymers while providing some unique additional benefits, including: *replacing microplastics with a natural ingredient *sustainable and biodegradable *moisturising the skin *imparting a superior skin feel *unique texture *having passed cosmetics ingredient safety studies covering: - skin irritation - skin sensitisation - skin blockage, and - skin penetration.

Koehler Group publishes figures for 2020 financial year: Despite the worldwide impact of the Covid-19 pandemic and the fall of total sales for German paper industry, the Koehler Group managed to perform relatively well in its market and maintained its competitive edge and invested more than 91 Million Euros during 2020. In the 2020 financial year, Koehler Group’s revenue fell by 11.7% to 769 million euros. The operating result of 66 million euros is significantly lower than the previous year’s figure and therefore significantly below target. Koehler Paper saw its sales volume fall by 1.5%, with the decrease essentially due to the decline caused by the Covid-19 pandemic. Koehler Group’s equity grew by 29 million to 590 million euros during the previous financial year. The equity ratio therefore equals 57.2%, with a decrease in the balance sheet total, and has clearly exceeded the long-term objective of more than 40%.